Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Agalsidase beta 35 mg powder for solution for injection vial | Is a | Product containing agalsidase beta (medicinal product) | false | Inferred relationship | Some | ||
Agalsidase beta 35 mg powder for solution for injection vial | Has active ingredient | Alpha-galactosidase | false | Inferred relationship | Some | ||
Agalsidase beta 35 mg powder for solution for injection vial | Has manufactured dose form | för injektion | false | Inferred relationship | Some | ||
Agalsidase beta 35 mg powder for solution for injection vial | Has active ingredient | biologisk produkt | false | Inferred relationship | Some | ||
Agalsidase beta 35 mg powder for solution for injection vial | Has active ingredient | Agalsidase beta (substance) | false | Inferred relationship | Some | ||
Agalsidase beta 35 mg powder for solution for injection vial | Is a | Product manufactured as parenteral dose form (product) | false | Inferred relationship | Some | ||
Agalsidase beta 35 mg powder for solution for injection vial | Has manufactured dose form | Powder for solution for injection | true | Inferred relationship | Some | ||
Agalsidase beta 35 mg powder for solution for injection vial | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
Agalsidase beta 35 mg powder for solution for injection vial | räkning av bas i aktiv ingrediens | ett | false | Inferred relationship | Some | ||
Agalsidase beta 35 mg powder for solution for injection vial | Has precise active ingredient | Agalsidase beta (substance) | true | Inferred relationship | Some | 1 | |
Agalsidase beta 35 mg powder for solution for injection vial | Has basis of strength substance (attribute) | Agalsidase beta (substance) | true | Inferred relationship | Some | 1 | |
Agalsidase beta 35 mg powder for solution for injection vial | Has presentation strength denominator unit (attribute) | Vial (unit of presentation) | true | Inferred relationship | Some | 1 | |
Agalsidase beta 35 mg powder for solution for injection vial | Has unit of presentation | Vial (unit of presentation) | true | Inferred relationship | Some | ||
Agalsidase beta 35 mg powder for solution for injection vial | har täljarvärde som visar styrka | 35 | false | Inferred relationship | Some | 1 | |
Agalsidase beta 35 mg powder for solution for injection vial | har nämnarvärde som visar styrka | ett | false | Inferred relationship | Some | 1 | |
Agalsidase beta 35 mg powder for solution for injection vial | Is a | Agalsidase beta only product in parenteral dose form | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets